18F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy. Valkema MJ, de Lussanet de la Sabloniere QG, Valkema R, Thomeer MGJ, et al. Nucl Med Commun 2023 Nov 20. doi: 10.1097/MNM.0000000000001793.

Read + Share

Amedeo Smart

Independent Medical Education

Valkema MJ, de Lussanet de la Sabloniere QG, Valkema R, Thomeer MGJ, et al. 18F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy. Nucl Med Commun 2023 Nov 20. doi: 10.1097/MNM.0000000000001793.
PMID: 37982560